Transcriptional activation of CSTB gene expression by transcription factor Sp3

Biochem Biophys Res Commun. 2023 Mar 15:649:71-78. doi: 10.1016/j.bbrc.2023.01.087. Epub 2023 Jan 30.

Abstract

CSTB has been reported to be associated with the pathogenesis of many malignant tumors, especially hepatocellular carcinoma (HCC). However, how the expression of this gene is regulated is largely unknown. We initially cloned and analyzed the promoter region of the CSTB gene by luciferase assay and the Sp3 binding site (CCCCGCCCCGCG) was found in it. The results of electrophoretic mobility shift assay (EMSA) and chromatin immunoprecipitation (ChIP) experiments verified that the transcription factor, Sp3 could bind to the " CCCCGCCCCGCG ″ site of the CSTB gene promoter. We showed that the overexpression of Sp3 significantly increased the endogenous mRNA and protein expression levels of CSTB, whereas knockdown of Sp3 decreased the mRNA and protein expression levels according to quantitative real-time PCR (qRT‒PCR) and western blotting. In conclusion, CSTB gene expression is closely regulated by transcription factor Sp3, which may be a potential mechanism for the dysregulation of CSTB expression in HCC.

Keywords: CSTB; Hepatocellular carcinoma; Sp3; Transcriptional regulation.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Carcinoma, Hepatocellular* / genetics
  • Gene Expression
  • Humans
  • Liver Neoplasms* / genetics
  • RNA, Messenger / genetics
  • RNA, Messenger / metabolism
  • Sp1 Transcription Factor / genetics
  • Sp1 Transcription Factor / metabolism
  • Sp3 Transcription Factor / genetics
  • Transcriptional Activation

Substances

  • Sp3 Transcription Factor
  • RNA, Messenger
  • Sp1 Transcription Factor